drugset / Trial / NCT01924520
Oral Multiple-dose Study in Patients With Major Depressive Disorder
Non-randomizedSingle-groupOpen-labelOther
Summary
A study was to evaluate the safety and plasma concentration changes of quetiapine after repeated administration of FK949E (extended-release formulation of quetiapine) in patients with major depressive disorder (MDD).
Timeline
- Start
- 2010-11
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | — | Oral |